Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer.

Trial Profile

Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 31 May 2016

At a glance

  • Drugs Ubidecarenone (Primary) ; Doxorubicin
  • Indications Early breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Jun 2015 Planned End Date changed from 1 Sep 2013 to 1 Sep 2016 ClinicalTrials.gov record
    • 30 Jun 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 14 Jul 2010 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top